127 related articles for article (PubMed ID: 8175170)
1. Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitor.
Stevens TL; Wei CM; Aahrus LL; Heublein DM; Kinoshita M; Matsuda Y; Burnett JC
Hypertension; 1994 May; 23(5):613-8. PubMed ID: 8175170
[TBL] [Abstract][Full Text] [Related]
2. Renal role of the endogenous natriuretic peptide system in acute congestive heart failure.
Stevens TL; Rasmussen TE; Wei CM; Kinoshita M; Matsuda Y; Burnett JC
J Card Fail; 1996 Jun; 2(2):119-25. PubMed ID: 8798113
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
[TBL] [Abstract][Full Text] [Related]
4. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
[TBL] [Abstract][Full Text] [Related]
5. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
Stevens TL; Burnett JC; Kinoshita M; Matsuda Y; Redfield MM
J Clin Invest; 1995 Mar; 95(3):1101-8. PubMed ID: 7883958
[TBL] [Abstract][Full Text] [Related]
6. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
Zhang PL; Jiménez W; Mackenzie HS; Guo J; Troy JL; Ros J; Angeli P; Arroyo V; Brenner BM
J Am Soc Nephrol; 1994 Oct; 5(4):1099-105. PubMed ID: 7849249
[TBL] [Abstract][Full Text] [Related]
7. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
[TBL] [Abstract][Full Text] [Related]
8. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
Sano T; Morishita Y; Matsuda Y; Yamada K
J Pharmacol Exp Ther; 1992 Feb; 260(2):825-31. PubMed ID: 1346647
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors.
Imura R; Sano T; Goto J; Yamada K; Matsuda Y
Mol Pharmacol; 1992 Dec; 42(6):982-90. PubMed ID: 1362244
[TBL] [Abstract][Full Text] [Related]
11. The renal action of atrial natriuretic peptide during control of glomerular filtration.
Burnett JC; Opgenorth TJ; Granger JP
Kidney Int; 1986 Jul; 30(1):16-9. PubMed ID: 2943930
[TBL] [Abstract][Full Text] [Related]
12. Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfiltration in diabetic rats.
Kikkawa R; Haneda M; Sakamoto K; Koya D; Shikano T; Nakanishi S; Matsuda Y; Shigeta Y
Biochem Biophys Res Commun; 1993 Jun; 193(2):700-5. PubMed ID: 8390251
[TBL] [Abstract][Full Text] [Related]
13. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
[TBL] [Abstract][Full Text] [Related]
14. Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man.
Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Pedersen EB
Int J Cardiol; 1991 Oct; 33(1):61-74. PubMed ID: 1657800
[TBL] [Abstract][Full Text] [Related]
15. Role of endogenous atrial natriuretic peptide on systemic and renal hemodynamics in heart failure rats.
Nishikimi T; Miura K; Minamino N; Takeuchi K; Takeda T
Am J Physiol; 1994 Jul; 267(1 Pt 2):H182-6. PubMed ID: 8048584
[TBL] [Abstract][Full Text] [Related]
16. Renal effects of high-dose natriuretic peptide receptor blockade in rats with congestive heart failure.
Zhang PL; Mackenzie HS; Totsune K; Troy JL; Brenner BM
Circ Res; 1995 Dec; 77(6):1240-5. PubMed ID: 7586237
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and renal functional effects of an antagonist of the guanylyl cyclase-linked ANF receptor.
Honrath U; Matsuda Y; Sonnenberg H
Regul Pept; 1994 Jan; 49(3):211-6. PubMed ID: 8140274
[TBL] [Abstract][Full Text] [Related]
18. Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
Chen HH; Lainchbury JG; Matsuda Y; Harty GJ; Burnett JC
Hypertension; 2001 Aug; 38(2):187-91. PubMed ID: 11509474
[TBL] [Abstract][Full Text] [Related]
19. Effects of nifedipine, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriuresis in dogs.
Takagi H; Takahara A; Tomura Y; Yamagata T; Hisa H; Satoh S
J Pharmacol Exp Ther; 1993 Oct; 267(1):456-61. PubMed ID: 8229776
[TBL] [Abstract][Full Text] [Related]
20. Short-term and long-term inhibition of endogenous atrial natriuretic peptide in dogs with early-stage heart failure.
Fukai D; Wada A; Tsutamoto T; Kinoshita M
Jpn Circ J; 1998 Aug; 62(8):604-10. PubMed ID: 9741739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
